Annual D&A
$33.13 M
+$11.99 M+56.74%
31 December 2023
Summary:
Iovance Biotherapeutics annual depreciation & amortization is currently $33.13 million, with the most recent change of +$11.99 million (+56.74%) on 31 December 2023. During the last 3 years, it has risen by +$24.41 million (+280.25%). IOVA annual D&A is now at all-time high.IOVA Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$11.15 M
+$284.00 K+2.61%
30 September 2024
Summary:
Iovance Biotherapeutics quarterly depreciation & amortization is currently $11.15 million, with the most recent change of +$284.00 thousand (+2.61%) on 30 September 2024. Over the past year, it has increased by +$1.27 million (+12.89%). IOVA quarterly D&A is now at all-time high.IOVA Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$41.63 M
+$1.27 M+3.15%
30 September 2024
Summary:
Iovance Biotherapeutics TTM depreciation & amortization is currently $41.63 million, with the most recent change of +$1.27 million (+3.15%) on 30 September 2024. Over the past year, it has increased by +$12.51 million (+42.97%). IOVA TTM D&A is now at all-time high.IOVA TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IOVA Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +56.7% | +12.9% | +43.0% |
| 3 y3 years | +280.3% | +181.2% | +139.2% |
| 5 y5 years | +3365.2% | +3439.1% | +3594.1% |
IOVA Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +280.3% | at high | +181.2% | at high | +197.8% |
| 5 y | 5 years | at high | +3365.2% | at high | +4323.8% | at high | +3594.1% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
Iovance Biotherapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $11.15 M(+2.6%) | $41.63 M(+3.2%) |
| June 2024 | - | $10.86 M(+9.7%) | $40.36 M(+8.1%) |
| Mar 2024 | - | $9.91 M(+2.0%) | $37.34 M(+12.7%) |
| Dec 2023 | $33.13 M(+56.7%) | $9.71 M(-1.6%) | $33.13 M(+13.8%) |
| Sept 2023 | - | $9.88 M(+25.9%) | $29.12 M(+19.1%) |
| June 2023 | - | $7.84 M(+37.6%) | $24.45 M(+11.9%) |
| Mar 2023 | - | $5.70 M(-0.2%) | $21.85 M(+3.4%) |
| Dec 2022 | $21.14 M(+51.2%) | $5.71 M(+9.7%) | $21.14 M(+6.2%) |
| Sept 2022 | - | $5.20 M(-0.9%) | $19.89 M(+6.6%) |
| June 2022 | - | $5.25 M(+5.4%) | $18.66 M(+15.3%) |
| Mar 2022 | - | $4.98 M(+11.5%) | $16.18 M(+15.8%) |
| Dec 2021 | $13.98 M(+60.5%) | $4.46 M(+12.6%) | $13.98 M(-19.7%) |
| Sept 2021 | - | $3.96 M(+42.8%) | $17.41 M(+26.6%) |
| June 2021 | - | $2.78 M(+0.1%) | $13.75 M(+22.4%) |
| Mar 2021 | - | $2.77 M(-64.9%) | $11.23 M(+28.9%) |
| Dec 2020 | $8.71 M(+7.3%) | $7.89 M(+2471.0%) | $8.71 M(+8.0%) |
| Sept 2020 | - | $307.00 K(+18.1%) | $8.07 M(-0.1%) |
| June 2020 | - | $260.00 K(+3.2%) | $8.07 M(-0.4%) |
| Mar 2020 | - | $252.00 K(-96.5%) | $8.10 M(-0.2%) |
| Dec 2019 | $8.12 M(+749.7%) | $7.25 M(+2201.0%) | $8.12 M(+620.8%) |
| Sept 2019 | - | $315.00 K(+9.0%) | $1.13 M(+6.0%) |
| June 2019 | - | $289.00 K(+6.6%) | $1.06 M(+6.4%) |
| Mar 2019 | - | $271.00 K(+7.5%) | $999.00 K(+4.5%) |
| Dec 2018 | $956.00 K(+0.4%) | $252.00 K(+0.4%) | $956.00 K(+1.1%) |
| Sept 2018 | - | $251.00 K(+11.6%) | $946.00 K(+0.5%) |
| June 2018 | - | $225.00 K(-1.3%) | $941.00 K(-1.9%) |
| Mar 2018 | - | $228.00 K(-5.8%) | $959.00 K(+0.7%) |
| Dec 2017 | $952.00 K(-2.7%) | $242.00 K(-1.6%) | $952.00 K(-4.8%) |
| Sept 2017 | - | $246.00 K(+1.2%) | $1.00 M(+10.9%) |
| June 2017 | - | $243.00 K(+10.0%) | $902.00 K(-3.0%) |
| Mar 2017 | - | $221.00 K(-23.8%) | $930.00 K(-4.9%) |
| Dec 2016 | $978.00 K | $290.00 K(+95.9%) | $978.00 K(-1.8%) |
| Sept 2016 | - | $148.00 K(-45.4%) | $996.00 K(-10.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2016 | - | $271.00 K(+0.7%) | $1.11 M(+2.9%) |
| Mar 2016 | - | $269.00 K(-12.7%) | $1.08 M(+8.4%) |
| Dec 2015 | $999.00 K(+1035.2%) | $308.00 K(+15.8%) | $999.00 K(+32.1%) |
| Sept 2015 | - | $266.00 K(+10.8%) | $756.00 K(+52.6%) |
| June 2015 | - | $240.00 K(+29.7%) | $495.30 K(+93.1%) |
| Mar 2015 | - | $185.00 K(+184.6%) | $256.50 K(+191.1%) |
| Dec 2014 | $88.00 K(+1157.1%) | $65.00 K(+1126.4%) | $88.10 K(+249.6%) |
| Sept 2014 | - | $5300.00(+341.7%) | $25.20 K(+16.1%) |
| June 2014 | - | $1200.00(-92.8%) | $21.70 K(+0.5%) |
| Mar 2014 | - | $16.60 K(+690.5%) | $21.60 K(+208.6%) |
| Dec 2013 | $7000.00(+12.9%) | $2100.00(+16.7%) | $7000.00(+7.7%) |
| Sept 2013 | - | $1800.00(+63.6%) | $6500.00(+3.2%) |
| June 2013 | - | $1100.00(-45.0%) | $6300.00(-7.4%) |
| Mar 2013 | - | $2000.00(+25.0%) | $6800.00(+6.3%) |
| Dec 2012 | $6200.00(+129.6%) | $1600.00(0.0%) | $6400.00(-113.2%) |
| Sept 2012 | - | $1600.00(0.0%) | -$48.40 K(+56.6%) |
| June 2012 | - | $1600.00(0.0%) | -$30.90 K(+123.9%) |
| Mar 2012 | - | $1600.00(-103.0%) | -$13.80 K(-611.1%) |
| Dec 2011 | $2700.00(-95.4%) | -$53.20 K(-378.5%) | $2700.00(-97.6%) |
| Sept 2011 | - | $19.10 K(+2.1%) | $112.00 K(+17.6%) |
| June 2011 | - | $18.70 K(+3.3%) | $95.20 K(+24.1%) |
| Mar 2011 | - | $18.10 K(-67.7%) | $76.70 K(+30.9%) |
| Dec 2010 | $58.60 K(+4407.7%) | $56.10 K(+2339.1%) | $58.60 K(+1992.9%) |
| Sept 2010 | - | $2300.00(+1050.0%) | $2800.00(+250.0%) |
| June 2010 | - | $200.00(>+9900.0%) | $800.00(-11.1%) |
| Mar 2010 | - | $0.00(-100.0%) | $900.00(-25.0%) |
| Dec 2009 | $1300.00(0.0%) | $300.00(0.0%) | $1200.00(0.0%) |
| Sept 2009 | - | $300.00(0.0%) | $1200.00(0.0%) |
| June 2009 | - | $300.00(0.0%) | $1200.00(0.0%) |
| Mar 2009 | - | $300.00(0.0%) | $1200.00(0.0%) |
| Dec 2008 | $1300.00 | $300.00(0.0%) | $1200.00(+33.3%) |
| Sept 2008 | - | $300.00(0.0%) | $900.00(+50.0%) |
| June 2008 | - | $300.00(0.0%) | $600.00(+100.0%) |
| Mar 2008 | - | $300.00 | $300.00 |
FAQ
- What is Iovance Biotherapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics annual D&A year-on-year change?
- What is Iovance Biotherapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics quarterly D&A year-on-year change?
- What is Iovance Biotherapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics TTM D&A year-on-year change?
What is Iovance Biotherapeutics annual depreciation & amortization?
The current annual D&A of IOVA is $33.13 M
What is the all time high annual D&A for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high annual depreciation & amortization is $33.13 M
What is Iovance Biotherapeutics annual D&A year-on-year change?
Over the past year, IOVA annual depreciation & amortization has changed by +$11.99 M (+56.74%)
What is Iovance Biotherapeutics quarterly depreciation & amortization?
The current quarterly D&A of IOVA is $11.15 M
What is the all time high quarterly D&A for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high quarterly depreciation & amortization is $11.15 M
What is Iovance Biotherapeutics quarterly D&A year-on-year change?
Over the past year, IOVA quarterly depreciation & amortization has changed by +$1.27 M (+12.89%)
What is Iovance Biotherapeutics TTM depreciation & amortization?
The current TTM D&A of IOVA is $41.63 M
What is the all time high TTM D&A for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high TTM depreciation & amortization is $41.63 M
What is Iovance Biotherapeutics TTM D&A year-on-year change?
Over the past year, IOVA TTM depreciation & amortization has changed by +$12.51 M (+42.97%)